Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Lexaria Bioscience Corp (NASDAQ: LEXX) closed the day trading at $0.89 down -33.58% from the previous closing price of $1.34. In other words, the price has decreased by -$33.58 from its previous closing price. On the day, 1.57 million shares were traded. LEXX stock price reached its highest trading level at $1.0 during the session, while it also had its lowest trading level at $0.8212.
Ratios:
For a better understanding of LEXX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.32 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 29 ’25 when BUNKA CHRISTOPHER bought 15,600 shares for $0.92 per share. The transaction valued at 14,375 led to the insider holds 270,012 shares of the business.
BUNKA CHRISTOPHER bought 11,900 shares of LEXX for $10,866 on Jul 30 ’25. The Director now owns 281,912 shares after completing the transaction at $0.91 per share. On Jul 29 ’25, another insider, McKechnie William Edward, who serves as the Director of the company, bought 5,000 shares for $0.91 each. As a result, the insider paid 4,532 and bolstered with 18,191 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEXX now has a Market Capitalization of 19781004 and an Enterprise Value of 17535898. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.86 while its Price-to-Book (P/B) ratio in mrq is 5.82. Its current Enterprise Value per Revenue stands at 24.841 whereas that against EBITDA is -1.519.
Stock Price History:
The Beta on a monthly basis for LEXX is 0.55, which has changed by -0.35576922 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, LEXX has reached a high of $2.43, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is -12.63%, while the 200-Day Moving Average is calculated to be -18.56%.
Shares Statistics:
Over the past 3-months, LEXX traded about 571.95K shares per day on average, while over the past 10 days, LEXX traded about 193200 shares per day. A total of 22.23M shares are outstanding, with a floating share count of 20.89M. Insiders hold about 6.45% of the company’s shares, while institutions hold 7.73% stake in the company. Shares short for LEXX as of 1764288000 were 605052 with a Short Ratio of 1.06, compared to 1761868800 on 741082. Therefore, it implies a Short% of Shares Outstanding of 605052 and a Short% of Float of 2.8399997999999997.
Earnings Estimates
The market rating for Lexaria Bioscience Corp (LEXX) is a result of the insights provided by 2.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.14 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.34 and -$0.68 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.75, with 2.0 analysts recommending between -$0.33 and -$1.17.
